NCT06006559 - A Study to Assess the Efficacy, Safety and Pharmacokinetics of EYU688 in Patients With Dengue Fever | Biotech Hunter

Enrollment

108

Participants

Timeline

Start Date

February 20, 2024

Primary Completion Date

September 7, 2026

Study Completion Date

September 7, 2026

Conditions

Dengue

Interventions

DRUG

EYU688

EYU688 administered by oral route

DRUG

Placebo

Matching placebo administered orally as capsules

Trial Locations (20)

13700

RECRUITING

Novartis Investigative Site, Seberang Jaya

25200

RECRUITING

Novartis Investigative Site, Kuantan

30450

RECRUITING

Novartis Investigative Site, Ipoh

98000

RECRUITING

Novartis Investigative Site, Miri

100000

RECRUITING

Novartis Investigative Site, Hanoi

169608

RECRUITING

Novartis Investigative Site, Singapore

302017

RECRUITING

Novartis Investigative Site, Jaipur

400008

WITHDRAWN

Novartis Investigative Site, Mumbai

411013

RECRUITING

Novartis Investigative Site, Pune

590010

RECRUITING

Novartis Investigative Site, Belagavi

600113

RECRUITING

Novartis Investigative Site, Chennai

700000

RECRUITING

Novartis Investigative Site, Ho Chi Minh City

760032

RECRUITING

Novartis Investigative Site, Santiago de Cali

69040-000

RECRUITING

Novartis Investigative Site, Manaus

71 635-580

RECRUITING

Novartis Investigative Site, Brasília

21040-360

RECRUITING

Novartis Investigative Site, Rio de Janeiro

18040-425

RECRUITING

Novartis Investigative Site, Sorocaba

15090 000

RECRUITING

Novartis Investigative Site, São José do Rio Preto

S308433

RECRUITING

Novartis Investigative Site, Singapore

04250

RECRUITING

Novartis Investigative Site, Haiphong